Nature on the slide?

In the beauty contest that is the annual citation report from ISI, linkurl:Nature;http://www.nature.com/nature/index.html has tripped and fallen off the stage. Having been the top journal in 2004 with an impact factor of 31.9, they slipped marginally behind linkurl:Science;http://www.sciencemag.org/ and linkurl:Cell;http://www.cell.com/ in 2005. But the latest figures, for 2006, show a gulf in linkurl:impact factors;http://en.wikipedia.org/wiki/impact_factors . Science comes in at 30.0, Cell

Written byRichard Gallagher
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
In the beauty contest that is the annual citation report from ISI, linkurl:Nature;http://www.nature.com/nature/index.html has tripped and fallen off the stage. Having been the top journal in 2004 with an impact factor of 31.9, they slipped marginally behind linkurl:Science;http://www.sciencemag.org/ and linkurl:Cell;http://www.cell.com/ in 2005. But the latest figures, for 2006, show a gulf in linkurl:impact factors;http://en.wikipedia.org/wiki/impact_factors . Science comes in at 30.0, Cell at 29.2 and Nature at 26.7. The numbers are calculated as the total number of citations in the year 2006 to papers published in the years 2004 and 2005, divided by the number of papers published in 2004 and 2005. That's three-and-a-half fewer citations on average for a Nature paper versus a Science paper. It is hard to say why this gap has opened up. It doesn't necessarily reflect a decline in the quality of papers published. I wonder if any readers have noticed a deterioration in Nature? I haven't. Maybe there's been a change in editorial strategy, downplaying certain highly cited areas like genomics? Can't say I've seen evidence of that either. Or perhaps it's just a blip. We'll have to wait a year to know that. One sure thing is that there will be concerns expressed at my former employers' office in Crinan Street, London and a quiet smile of satisfaction at my other former employer on New York Avenue in DC. No idea what will be happening in Kendall Square, Cambridge.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies